Printer Friendly

Dopamine receptor genes found, cloned.

Dopamine receptor genes found, cloned

Scientists have plucked from human cells two genes that guide production of molecular switches important in schizophrenia and Parkinsonhs disease. With the genes in hand, the researchers have grown cultured cells engineered to contain the switches, which respond to a chemical messenger called dopamine. The feat promises to simplify studies of the switches' functions and speed development of new drugs.

For years, neuroscientists and psychologists have been frustrated by their lack of tools to investigate dopamine, a neurochemical intimately involved in such diverse functions as motor coordination and the experience of pleasure. Dopamine shortages in certain brain regions cause Parkinson's disease, but nobody knows why these shortages occur. And while some schizophrenia drugs tweak the dopamine system, scientists still don't know why these drugs help.

In 1988, researchers isolated and inserted into cultured cells the gene for a cell-surface receptor called D2, which responds to dopamine by inhibiting certain chemical reactions inside cells. Now, in the Sept. 6 NATURE, three separate research teams say they've cloned a related protein, D1, that responds to dopamine by stimulating, rather than inhibiting, those same cellular reactions. The teams were led by Allen Dearry at the Duke University Medical Center in Durham, N.C., Olivier Civelli of the Oregon Health Sciences University in Portland, and Brian F. O'Dowd of the University of Toronto.

And in the Sept. 13 NATURE, Pierre Sokoloff and his colleagues at INSERM in Paris, France, report cloning a third, previously unrecognized dopamine receptor gene, which they call D3.

Researchers say experiments on cultured cells bearing the newly cloned genes could simplify laboratory investigations of the molecular mechanisms underlying Parkinson's and schizophrenia. They add that cultured cells engineered to bear both stimulatory and inhibitory dopamine receptors could provide new insights into dopamine regulation and aid in the development of new drugs to alter dopamine's activity.
COPYRIGHT 1990 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1990, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Science News
Date:Sep 15, 1990
Words:309
Previous Article:Corticosteroids can't counter caustics.
Next Article:Wiring enzymes to sense biochemicals.
Topics:


Related Articles
Cancer-fighting cell receptor cloned.
Gene in the bottle: a controversial alcoholism gene gets a new twist.
Abusive inheritance; gene implicated in alcoholism may influence a wide array of drug abuse.
Gene tied to excitable personality.
New data challenge personality gene.
A fantastical experiment: the science behind the controversial cloning of Dolly.
Impossible Elephants.
Cloning extends life of cells--and cows?
Dolly was lucky: scientists warn that cloning is too dangerous for people.
Cloning's ups and downs. (Biomedicine).

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters